Literature DB >> 21107580

Unraveling the genetics of otitis media: from mouse to human and back again.

Marie S Rye1, Mahmood F Bhutta, Michael T Cheeseman, David Burgner, Jenefer M Blackwell, Steve D M Brown, Sarra E Jamieson.   

Abstract

Otitis media (OM) is among the most common illnesses of early childhood, characterised by the presence of inflammation in the middle ear cavity. Acute OM and chronic OM with effusion (COME) affect the majority of children by school age and have heritability estimates of 40-70%. However, the majority of genes underlying this susceptibility are, as yet, unidentified. One method of identifying genes and pathways that may contribute to OM susceptibility is to look at mouse mutants displaying a comparable phenotype. Single-gene mouse mutants with OM have identified a number of genes, namely, Eya4, Tlr4, p73, MyD88, Fas, E2f4, Plg, Fbxo11, and Evi1, as potential and biologically relevant candidates for human disease. Recent studies suggest that this "mouse-to-human" approach is likely to yield relevant data, with significant associations reported between polymorphisms at the FBXO11, TLR4, and PAI1 genes and disease in humans. An association between TP73 and chronic rhinosinusitis has also been reported. In addition, the biobanks of available mouse mutants provide a powerful resource for functional studies of loci identified by future genome-wide association studies of OM in humans. Mouse models of OM therefore are an important component of current approaches attempting to understand the complex genetic susceptibility to OM in humans, and which aim to facilitate the development of preventative and therapeutic interventions for this important and common disease.

Entities:  

Mesh:

Year:  2010        PMID: 21107580     DOI: 10.1007/s00335-010-9295-1

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  94 in total

1.  The heritability of otitis media: a twin and triplet study.

Authors:  M L Casselbrant; E M Mandel; P A Fall; H E Rockette; M Kurs-Lasky; C D Bluestone; R E Ferrell
Journal:  JAMA       Date:  1999-12-08       Impact factor: 56.272

2.  Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media.

Authors:  Selma P Wiertsema; Bjorn L Herpers; Reinier H Veenhoven; Marcel M M Salimans; Henk J T Ruven; Elisabeth A M Sanders; Ger T Rijkers
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

3.  Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Authors:  S P Wiertsema; S-K Khoo; G Baynam; R H Veenhoven; I A Laing; G A Zielhuis; G T Rijkers; J Goldblatt; P N Lesouëf; E A M Sanders
Journal:  Clin Vaccine Immunol       Date:  2006-08

4.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

5.  E2F4 is essential for normal erythrocyte maturation and neonatal viability.

Authors:  P O Humbert; C Rogers; S Ganiatsas; R L Landsberg; J M Trimarchi; S Dandapani; C Brugnara; S Erdman; M Schrenzel; R T Bronson; J A Lees
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

6.  Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription.

Authors:  Hirofumi Jono; Tsuyoshi Shuto; Haidong Xu; Hirofumi Kai; David J Lim; James R Gum; Young S Kim; Shoji Yamaoka; Xin-Hua Feng; Jian-Dong Li
Journal:  J Biol Chem       Date:  2002-09-16       Impact factor: 5.157

7.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

8.  HLA frequency in patients with chronic secretory otitis media.

Authors:  O Kalm; U Johnson; K Prellner
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1994-08       Impact factor: 1.675

9.  The sequence of the human genome.

Authors:  J C Venter; M D Adams; E W Myers; P W Li; R J Mural; G G Sutton; H O Smith; M Yandell; C A Evans; R A Holt; J D Gocayne; P Amanatides; R M Ballew; D H Huson; J R Wortman; Q Zhang; C D Kodira; X H Zheng; L Chen; M Skupski; G Subramanian; P D Thomas; J Zhang; G L Gabor Miklos; C Nelson; S Broder; A G Clark; J Nadeau; V A McKusick; N Zinder; A J Levine; R J Roberts; M Simon; C Slayman; M Hunkapiller; R Bolanos; A Delcher; I Dew; D Fasulo; M Flanigan; L Florea; A Halpern; S Hannenhalli; S Kravitz; S Levy; C Mobarry; K Reinert; K Remington; J Abu-Threideh; E Beasley; K Biddick; V Bonazzi; R Brandon; M Cargill; I Chandramouliswaran; R Charlab; K Chaturvedi; Z Deng; V Di Francesco; P Dunn; K Eilbeck; C Evangelista; A E Gabrielian; W Gan; W Ge; F Gong; Z Gu; P Guan; T J Heiman; M E Higgins; R R Ji; Z Ke; K A Ketchum; Z Lai; Y Lei; Z Li; J Li; Y Liang; X Lin; F Lu; G V Merkulov; N Milshina; H M Moore; A K Naik; V A Narayan; B Neelam; D Nusskern; D B Rusch; S Salzberg; W Shao; B Shue; J Sun; Z Wang; A Wang; X Wang; J Wang; M Wei; R Wides; C Xiao; C Yan; A Yao; J Ye; M Zhan; W Zhang; H Zhang; Q Zhao; L Zheng; F Zhong; W Zhong; S Zhu; S Zhao; D Gilbert; S Baumhueter; G Spier; C Carter; A Cravchik; T Woodage; F Ali; H An; A Awe; D Baldwin; H Baden; M Barnstead; I Barrow; K Beeson; D Busam; A Carver; A Center; M L Cheng; L Curry; S Danaher; L Davenport; R Desilets; S Dietz; K Dodson; L Doup; S Ferriera; N Garg; A Gluecksmann; B Hart; J Haynes; C Haynes; C Heiner; S Hladun; D Hostin; J Houck; T Howland; C Ibegwam; J Johnson; F Kalush; L Kline; S Koduru; A Love; F Mann; D May; S McCawley; T McIntosh; I McMullen; M Moy; L Moy; B Murphy; K Nelson; C Pfannkoch; E Pratts; V Puri; H Qureshi; M Reardon; R Rodriguez; Y H Rogers; D Romblad; B Ruhfel; R Scott; C Sitter; M Smallwood; E Stewart; R Strong; E Suh; R Thomas; N N Tint; S Tse; C Vech; G Wang; J Wetter; S Williams; M Williams; S Windsor; E Winn-Deen; K Wolfe; J Zaveri; K Zaveri; J F Abril; R Guigó; M J Campbell; K V Sjolander; B Karlak; A Kejariwal; H Mi; B Lazareva; T Hatton; A Narechania; K Diemer; A Muruganujan; N Guo; S Sato; V Bafna; S Istrail; R Lippert; R Schwartz; B Walenz; S Yooseph; D Allen; A Basu; J Baxendale; L Blick; M Caminha; J Carnes-Stine; P Caulk; Y H Chiang; M Coyne; C Dahlke; A Deslattes Mays; M Dombroski; M Donnelly; D Ely; S Esparham; C Fosler; H Gire; S Glanowski; K Glasser; A Glodek; M Gorokhov; K Graham; B Gropman; M Harris; J Heil; S Henderson; J Hoover; D Jennings; C Jordan; J Jordan; J Kasha; L Kagan; C Kraft; A Levitsky; M Lewis; X Liu; J Lopez; D Ma; W Majoros; J McDaniel; S Murphy; M Newman; T Nguyen; N Nguyen; M Nodell; S Pan; J Peck; M Peterson; W Rowe; R Sanders; J Scott; M Simpson; T Smith; A Sprague; T Stockwell; R Turner; E Venter; M Wang; M Wen; D Wu; M Wu; A Xia; A Zandieh; X Zhu
Journal:  Science       Date:  2001-02-16       Impact factor: 47.728

10.  Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant.

Authors:  Hilda Tateossian; Rachel E Hardisty-Hughes; Susan Morse; Maria R Romero; Helen Hilton; Charlotte Dean; Steve Dm Brown
Journal:  Pathogenetics       Date:  2009-07-06
View more
  31 in total

1.  Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.

Authors:  Suzanne J C Verhaegh; Kim Stol; Corné P de Vogel; Kristian Riesbeck; Eric R Lafontaine; Timothy F Murphy; Alex van Belkum; Peter W M Hermans; John P Hays
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

2.  Genetic variation in thyroid folliculogenesis influences susceptibility to hypothyroidism-induced hearing impairment.

Authors:  Amanda H Mortensen; Qing Fang; Michelle T Fleming; Thomas J Jones; Alexandre Z Daly; Kenneth R Johnson; Sally A Camper
Journal:  Mamm Genome       Date:  2019-02-18       Impact factor: 2.957

Review 3.  Genetic contributors to otitis media: agnostic discovery approaches.

Authors:  E Kaitlynn Allen; Ani Manichaikul; Michèle M Sale
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

Review 4.  The N-end rule pathway.

Authors:  Takafumi Tasaki; Shashikanth M Sriram; Kyong Soo Park; Yong Tae Kwon
Journal:  Annu Rev Biochem       Date:  2012-04-10       Impact factor: 23.643

Review 5.  Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Authors:  Arwa Kurabi; Kwang Pak; Allen F Ryan; Stephen I Wasserman
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 6.  What have we learned from murine models of otitis media?

Authors:  Hayley E Tyrer; Michael Crompton; Mahmood F Bhutta
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 7.  [The role of innate immunity in otitis media].

Authors:  M Wigand; T K Hoffmann; A F Ryan; B Wollenberg; A Leichtle
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

8.  TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses.

Authors:  R Tomasini; V Secq; L Pouyet; A K Thakur; M Wilhelm; J Nigri; S Vasseur; P Berthezene; E Calvo; G Melino; T W Mak; J L Iovanna
Journal:  Cell Death Differ       Date:  2012-09-14       Impact factor: 15.828

9.  Otitis media in the Tgif knockout mouse implicates TGFβ signalling in chronic middle ear inflammatory disease.

Authors:  Hilda Tateossian; Susan Morse; Andrew Parker; Philomena Mburu; Nick Warr; Abraham Acevedo-Arozena; Michael Cheeseman; Sara Wells; Steve D M Brown
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

10.  Mcph1-deficient mice reveal a role for MCPH1 in otitis media.

Authors:  Jing Chen; Neil Ingham; Simon Clare; Claire Raisen; Valerie E Vancollie; Ozama Ismail; Rebecca E McIntyre; Stephen H Tsang; Vinit B Mahajan; Gordon Dougan; David J Adams; Jacqueline K White; Karen P Steel
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.